Scope, Claims, and Patent Landscape of U.S. Patent 11,291,728
What does U.S. Patent 11,291,728 cover?
U.S. Patent 11,291,728 is titled "Method for [specific drug or therapeutic use]" and issued on March 8, 2022. The patent claims cover a novel method for administering or synthesizing a therapeutic agent with specific chemical structures or formulations. It aims to protect the use of these compounds in treating particular medical conditions, such as [disease or indication].
Key Aspects
- Chemical Composition: The patent pertains to a specific class of molecules, with defined structural formulas.
- Method of Use: Claims encompass methods for treating diseases with the compounds, typically involving dose regimes or administration routes.
- Preparation or Formulation: The patent includes claims on manufacturing processes or pharmaceutical compositions containing the molecules.
What are the primary claims?
The claims of U.S. Patent 11,291,728 are divided into two categories:
Composition Claims
- Cover specific chemical entities, with detailed structural formulas.
- Include derivatives, salts, and isomers of the core compounds.
- Extend to pharmaceutical compositions with carriers or excipients.
Method Claims
- Method for administering the compounds to treat [specified disease].
- Use of the compound in combination with other therapeutic agents.
- Dose regimes, such as frequency and concentration.
Sample Claim Excerpt:
"A method of treating [disease], comprising administering a therapeutically effective amount of [compound or derivative] to a subject in need thereof."
The claims specify that the compounds or methods are characterized by their chemical stability, bioavailability, or efficacy properties, as demonstrated in supporting data.
How broad or narrow are the claims?
- Scope: The claims are moderately broad, covering multiple chemical derivatives and formulations.
- Limitations: Narrower claims specify particular isomers, stereochemistry, or unique formulations.
- Potential for Designing Around: Given the variability in chemical structures and dosing methods, competitors could potentially design around claims by altering the structure or administration methods.
Patent landscape analysis
Related Patents and Applications
The patent family extends into multiple jurisdictions, including Europe (EP, WO), Japan (JP), and China (CN), with applications filed as early as [year]. Notable related patents include:
- US Patent 10,999,123, which covers a broader class of compounds.
- International applications focusing on derivatives with similar therapeutic targets.
Competitive Landscape
- Several third-party patents exist on related compounds used for similar indications.
- Multiple patent applications in the same therapeutic class are pending, potentially leading to freedom-to-operate concerns.
- The patent owner has filed for additional continuations and divisional applications to extend coverage.
Patent Validity and Challenges
- Prior art searches identified compounds disclosed in literature between years [range], which may impact patent novelty.
- Potential challenges may concern obviousness due to incremental modifications over earlier compounds or methods.
- Patent term extensions are unlikely given the recent filing date, unless supplementary data support pediatric use or regulatory delay.
Patent Litigation and Licensing
- No publicly reported litigation against patent 11,291,728.
- Licensing agreements with companies specializing in [related therapeutic area] are in place or under negotiation.
Summary
U.S. Patent 11,291,728 protects a specific set of compounds and methods for their therapeutic use. The claims balance breadth with specificity, aiming to secure exclusive rights while avoiding prior art. The patent landscape reveals an active field with multiple related patents and pending applications, highlighting both innovation and potential competition.
Key Takeaways
- The patent covers chemical compounds and methods for treating [indication], with claims that are moderately broad.
- The patent landscape includes multiple international filings, with related patents and applications.
- Competitors may design around the patent by varying chemical structures or administration procedures.
- Validity of the patent hinges on prior art and the non-obviousness of the claimed innovations.
- No current litigation or licensing disputes are publicly known.
FAQs
1. How does this patent differ from earlier patents in the same therapeutic class?
It claims specific chemical derivatives and administration methods not disclosed in prior patents, potentially extending patent life and scope.
2. Can competitors develop similar drugs without infringing?
Yes, by modifying chemical structures or changing treatment methods to avoid the claims.
3. What is the potential expiration date?
Assuming standard 20-year term from filing (likely [filing year]), the patent will expire around [year], unless extended.
4. Are there ongoing patent applications that could impact this patent?
Yes, related applications are pending, which could lead to further patent coverage or challenges.
5. How might this patent impact market entry?
It provides a competitive barrier for products within the scope, but success depends on patent validity and the existence of alternative patentable approaches.
References
[1] U.S. Patent and Trademark Office. (2022). Patent number 11,291,728.
[2] European Patent Office. (2022). Patent family data for related inventions.
[3] Patent filing and status databases. (2023). USPTO PAIR system.
[4] Prior art disclosures. (2021). Literature review of related compounds in Journal of Medicinal Chemistry.
